FAIRLESS HILLS, Pa. — Pfizer Inc. reported a 32% plunge in second-quarter profit, mainly due to the global coronavirus pandemic limiting marketing of and new prescriptions for its medicines, even as the drugmaker races to develop a vaccine.
Read more >